Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News
Financial Results · Q3 2026

United Health Products Q3 2026 Results: Net Loss of $185K, Loss Narrows

United Health Products, Inc. reported zero revenue for the nine months ended September 30, 2026, as it continues to seek regulatory approval for its CelluSTAT hemostatic gauze. The company recorded a net loss of $785,250 for the period, a significant improvement from the $2,150,775 loss in the prior year, primarily due to reduced selling, general, and administrative expenses.

Q3 2026 at a glance · $ million
MetricQ3 2026Q3 2025
Revenue0.00.0
Net income-0.2-0.3
EPS (diluted, $ a share)$-0.00$-0.00

A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.

Source

10-Q filed with the SEC, OTC: UEEC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.

Read the filing ↗

United Health Products, Inc.: key numbers

Shares outstanding
266.14MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Orthopedic, Prosthetic & Surgical Appliances & SuppliesSIC 3842

Today's reference numbers, updated daily. Not a valuation or a recommendation.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.